INTELLIGENT BIO SOLUTIONS INC.INBSEarnings & Financial Report
The Institute of Robotics and Intelligent Systems (IRIS) is part of the ETH Zurich, Switzerland. It replaced the existing Institute of Robotics, of the ETH Zurich in October 2002, when Prof. Bradley J. Nelson moved from the University of Minnesota, United States, to ETH Zurich, and succeeded the Prof. Dr. Gerhard Schweitzer.
Revenue
$728.9K
Gross Profit
$341.4K
Operating Profit
$-2.6M
Net Profit
$-2.5M
Gross Margin
46.8%
Operating Margin
-350.3%
Net Margin
-349.0%
YoY Growth
-11.5%
EPS
$-0.44
INTELLIGENT BIO SOLUTIONS INC. Q3 FY2025 Financial Summary
INTELLIGENT BIO SOLUTIONS INC. reported revenue of $728.9K (down 11.5% YoY) for Q3 FY2025, with a net profit of $-2.5M (up 14.6% YoY) (-349.0% margin). Cost of goods sold was $387.5K, operating expenses totaled $2.9M.
Key Financial Metrics
| Total Revenue | $728.9K |
|---|---|
| Net Profit | $-2.5M |
| Gross Margin | 46.8% |
| Operating Margin | -350.3% |
| Report Period | Q3 FY2025 |
INTELLIGENT BIO SOLUTIONS INC. Annual Revenue by Year
INTELLIGENT BIO SOLUTIONS INC. annual revenue history includes year-by-year totals (for example, 2025 revenue was $3.1M).
| Year | Annual Revenue |
|---|---|
| 2025 | $3.1M |
| 2024 | $3.1M |
| 2023 | $1.3M |
INTELLIGENT BIO SOLUTIONS INC. Quarterly Revenue & Net Profit History
INTELLIGENT BIO SOLUTIONS INC. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q2 FY2026 | $896.8K | +47.6% | $-2.7M | -298.6% |
| Q1 FY2026 | $1.1M | +27.5% | $-3.0M | -268.3% |
| Q4 FY2025 | $843.9K | +15.9% | $-3.1M | -366.2% |
| Q3 FY2025 | $728.9K | -11.5% | $-2.5M | -349.0% |
| Q2 FY2025 | $607.5K | -20.5% | $-2.2M | -370.3% |
| Q1 FY2025 | $872.3K | +9.6% | $-2.7M | -307.9% |
| Q4 FY2024 | $727.8K | +452.2% | $-2.8M | -382.5% |
| Q3 FY2024 | $823.8K | +80.2% | $-3.0M | -361.5% |
Income Statement
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $823800 | $727824 | $872287 | $607494 | $728867 | $843884 | $1.1M | $896774 |
| YoY Growth | 80.2% | 452.2% | 9.6% | -20.5% | -11.5% | 15.9% | 27.5% | 47.6% |
Balance Sheet
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $17.0M | $13.8M | $11.7M | $8.7M | $9.6M | $8.2M | $10.0M | $17.7M |
| Liabilities | $6.0M | $5.6M | $5.8M | $4.5M | $4.6M | $5.4M | $6.6M | $6.8M |
| Equity | $11.1M | $8.3M | $6.1M | $4.4M | $5.1M | $3.0M | $3.6M | $11.1M |
Cash Flow
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-2.4M | $-2.9M | $-2.4M | $-2.3M | $-2.8M | $-2.2M | $-2.8M | $-1.6M |